- our experts
- Student Sphere
- Hotel & Travel
Anticancer agents are drugs used to treat cancer by inhibiting the growth and division of cancer cells. Here are some examples of anticancer agents:
Chemotherapy agents: These drugs work by interfering with the DNA or RNA of cancer cells, thus preventing the cells from dividing and leading to cell death. Examples of chemotherapy agents include cyclophosphamide and cisplatin.
Targeted therapy agents: These drugs work by targeting specific proteins or pathways that are important for the growth and survival of cancer cells. Examples of targeted therapy agents include imatinib and trastuzumab.
Immunotherapy agents: These drugs work by boosting the immune system's ability to recognize and attack cancer cells. Examples of immunotherapy agents include checkpoint inhibitors and CAR-T cell therapy.
Hormonal therapy agents: These drugs work by blocking the effects of hormones that can stimulate the growth of certain types of cancer cells. Examples of hormonal therapy agents include tamoxifen and leuprolide.
Radiopharmaceuticals: These drugs contain radioactive particles that can be targeted to specific cancer cells, thus delivering a high dose of radiation directly to the cancer cells. Examples of radiopharmaceuticals include iodine-131 and lutetium-177.
Overall, anticancer agents are an important tool in the treatment of cancer, and can be used to treat a wide range of cancers, from early-stage to advanced-stage cancers. However, these agents can also cause side effects, some of which can be severe, and can also affect normal cells in addition to cancer cells. Therefore, it is important to use anticancer agents only when necessary and as directed by a healthcare professional.
The global market for anticancer agents is a significant segment of the pharmaceutical industry, given the high prevalence of cancer and the increasing demand for effective treatments.
According to a report by Zion Market Research, the global market for anticancer drugs was valued at USD 98.9 billion in 2020 and is expected to reach USD 193.8 billion by 2028, growing at a CAGR of 8.2% during the forecast period (2021-2028).
The market for anticancer agents is segmented into various categories based on drug class, including chemotherapy drugs, targeted therapy drugs, immunotherapy drugs, and hormonal therapy drugs. Chemotherapy drugs are the largest segment of the market, followed by targeted therapy drugs.
The market is also segmented by geography, with North America and Europe accounting for the largest market shares due to the high prevalence of cancer in these regions and the presence of major pharmaceutical companies. The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, driven by increasing awareness and access to healthcare, as well as rising disposable income.
The demand for anticancer agents is driven by several factors, including the increasing prevalence of cancer, the growing focus on early detection and treatment, and the increasing availability of effective therapies. Additionally, the rise in healthcare expenditure and the increasing availability of reimbursement policies are also contributing to the growth of the market.
Despite the promising growth prospects, the market for anticancer agents is facing some challenges, including the high cost of research and development, regulatory hurdles, and the increasing preference for non-pharmacological therapies.
Overall, the market for anticancer agents is expected to continue growing in the coming years, driven by the increasing demand for effective treatments for cancer and advancements in drug development technology.
ALSO READ Drugs and Drug Targets Drug Discovery, Design and Development Pharmacokinetics and Pharmacodynamics Computer Aided Drug Design Drug Metabolism Pharmaceutical Biotechnology Combinatorial Chemistry Novel Drug Delivery Systems Formulations Natural Products Traditional Medicine Drug Repurposing and Drug Repositioning Precision Medicine Personalized Therapies Drug Development and Clinical Trials Biomarker Discovery and Development Biologics and Biosimilars Vaccines and Immunotherapies Steam Cells and Regenerative Medicine Drug Safety and Pharmacovigilance Pharmacogenomics Toxicology Rare Diseases Receptors as Target for Drug Discovery Drugs Affecting the Cardiovascular System Drugs Affecting the Central Nervous System Drugs Affecting Hormonal Systems Chemotherapeutic Agents Antibacterial Agents Antiviral Agents Anticancer Agents The Opioid Analgesics Anti-Ulcer Agents Non-Steroidal Anti Inflammatory Drugs Steroids Antibiotics Antineoplastic Agents Anthelmintics Sulphonamides Artificial Intelligence and Machine Learning in Drug Discovery and Development Genomics and Proteomics in Drug Discovery and Development Gene Therapy and Genome Editing in Treating Genetic Diseases Nanotechnology in Drug Delivery and Imaging Virtual and Augmented Reality in Drug Discovery and Development Patient Engagement and Patient-Centered Drug Development Big Data Analytics in Drug Discovery and Development
Medicinal Chemistry Conferences 2023 Drug Design Conferences Natural Products Conferences Drug Discovery Conferences 2023 Medicinal Chemistry Conferences 2023 Canada Medicinal Chemistry Conferences 2023 Middle East Pharmaceutical Chemistry Conferences Toxicology Conferences Combinatorial Chemistry Conferences Precision Medicine Conferences Medicinal Chemistry Conferences